DelveInsight says chronic spontaneous urticaria market reached about $2 billion in 2025

The market research report projects growth through 2036 as diagnosed cases rise and new therapies from Celldex, Sanofi, Jasper Therapeutics and others advance.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.